Study of Bavituximab, Axitinib, and Avelumab in Advanced Hepatocellular Carcinoma
Clinical trial NCT05249569 · TERMINATED
Trial details
- NCT number
- NCT05249569
- Sponsor
- University of Texas Southwestern Medical Center
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-11-04
- Primary completion
- 2022-12-30
- Enrollment
- 1
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.